The Tuberculosis Prodrug Isoniazid Bound to Activating Peroxidases*

Isoniazid (INH, isonicotinic acid hydrazine) is one of only two therapeutic agents effective in treating tuberculosis. This prodrug is activated by the heme enzyme catalase peroxidase (KatG) endogenous to Mycobacterium tuberculosis but the mechanism of activation is poorly understood, in part because the binding interaction has not been properly established. The class I peroxidases ascorbate peroxidase (APX) and cytochrome c peroxidase (CcP) have active site structures very similar to KatG and are also capable of activating isoniazid. We report here the first crystal structures of complexes of isoniazid bound to APX and CcP. These are the first structures of isoniazid bound to any activating enzymes. The structures show that isoniazid binds close to the δ-heme edge in both APX and CcP, although the precise binding orientation varies slightly in the two cases. A second binding site for INH is found in APX at the γ-heme edge close to the established ascorbate binding site, indicating that the γ-heme edge can also support the binding of aromatic substrates. We also show that in an active site mutant of soybean APX (W41A) INH can bind directly to the heme iron to become an inhibitor and in a different mode when the distal histidine is replaced by alanine (H42A). These structures provide the first unambiguous evidence for the location of the isoniazid binding site in the class I peroxidases and provide rationalization of isoniazid resistance in naturally occurring KatG mutant strains of M. tuberculosis.

[1]  T. Poulos.  The Janus nature of heme. , 2007, Natural product reports.

[2]  M. Joyce,et al.  Conformational Mobility in the Active Site of a Heme Peroxidase* , 2006, Journal of Biological Chemistry.

[3]  K. Brown,et al.  Enzyme-catalyzed Mechanism of Isoniazid Activation in Class I and Class III Peroxidases* , 2004, Journal of Biological Chemistry.

[4]  Jesmin,et al.  Crystal Structure of Mycobacterium tuberculosis Catalase-Peroxidase* , 2004, Journal of Biological Chemistry.

[5]  K. Brown,et al.  Crystal structure of the ascorbate peroxidase-salicylhydroxamic acid complex. , 2004, Biochemistry.

[6]  S. Girotto,et al.  Conformational differences in Mycobacterium tuberculosis catalase-peroxidase KatG and its S315T mutant revealed by resonance Raman spectroscopy. , 2003, Biochemistry.

[7]  M. Mewies,et al.  Crystal structure of the ascorbate peroxidase–ascorbate complex , 2003, Nature Structural Biology.

[8]  M. Mewies,et al.  Substrate binding and catalytic mechanism in ascorbate peroxidase: evidence for two ascorbate binding sites. , 2002, Biochemistry.

[9]  K. Brown,et al.  Oxidation of isoniazid by manganese and Mycobacterium tuberculosis catalase-peroxidase yields a new mechanism of activation. , 2001, Journal of the American Chemical Society.

[10]  S. Takahashi,et al.  Binding of salicylhydroxamic acid and several aromatic donor molecules to Arthromyces ramosus peroxidase, investigated by X-ray crystallography, optical difference spectroscopy, NMR relaxation, molecular dynamics, and kinetics. , 1999, Biochemistry.

[11]  P. Weber,et al.  Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation , 1999, Nature Structural Biology.

[12]  T. Poulos,et al.  Crystal Structure of Constitutive Endothelial Nitric Oxide Synthase A Paradigm for Pterin Function Involving a Novel Metal Center , 1998, Cell.

[13]  H. Soini,et al.  A Ser315Thr Substitution in KatG Is Predominant in Genetically Heterogeneous Multidrug-Resistant Mycobacterium tuberculosis Isolates Originating from the St. Petersburg Area in Russia , 1998, Antimicrobial Agents and Chemotherapy.

[14]  D. J. Schuller,et al.  Structural interactions between horseradish peroxidase C and the substrate benzhydroxamic acid determined by X-ray crystallography. , 1998, Biochemistry.

[15]  J. Tainer,et al.  Structure of nitric oxide synthase oxygenase dimer with pterin and substrate. , 1998, Science.

[16]  K. Brown,et al.  Purification and Characterization of Recombinant Catalase-Peroxidase, Which Confers Isoniazid Sensitivity inMycobacterium tuberculosis * , 1997, The Journal of Biological Chemistry.

[17]  K. Fukuyama,et al.  Binding mode of benzhydroxamic acid to Arthromyces ramosus peroxidase shown by X‐ray crystallographic analysis of the complex at 1.6 Å resolution , 1997, FEBS letters.

[18]  W. Haas,et al.  Molecular analysis of katG gene mutations in strains of Mycobacterium tuberculosis complex from Africa , 1997, Antimicrobial agents and chemotherapy.

[19]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[20]  P. Schultz,et al.  Overexpression, Purification, and Characterization of the Catalase-peroxidase KatG from Mycobacterium tuberculosis* , 1997, The Journal of Biological Chemistry.

[21]  G. Bai,et al.  Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis , 1995, Antimicrobial agents and chemotherapy.

[22]  D. Rouse,et al.  Molecular mechanisms of isoniazid resistance in Mycobacterium tuberculosis and Mycobacterium bovis , 1995, Infection and immunity.

[23]  S. Cole,et al.  Missense mutations in the catalase‐peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis , 1995, Molecular microbiology.

[24]  T. Poulos,et al.  The crystal structure of manganese peroxidase from Phanerochaete chrysosporium at 2.06-A resolution. , 1994, The Journal of biological chemistry.

[25]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[26]  S. Cole,et al.  The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis , 1992, Nature.

[27]  J. Kraut,et al.  Yeast cytochrome c peroxidase: mutagenesis and expression in Escherichia coli show tryptophan-51 is not the radical site in compound I. , 1987, Biochemistry.

[28]  B C Finzel,et al.  Crystal structure of yeast cytochrome c peroxidase refined at 1.7-A resolution. , 1984, The Journal of biological chemistry.

[29]  N. Xuong,et al.  The crystal structure of cytochrome c peroxidase. , 1980, The Journal of biological chemistry.

[30]  P. Evans,et al.  Scaling and assessment of data quality. , 2006, Acta crystallographica. Section D, Biological crystallography.

[31]  P. Afonine,et al.  research papers Acta Crystallographica Section D Biological , 2003 .

[32]  W. Delano.  The PyMOL Molecular Graphics System , 2002 .

[33]  D van Soolingen,et al.  Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance. , 1996, The Journal of infectious diseases.

[34]  F. Cockerill,et al.  Rapid identification of a point mutation of the Mycobacterium tuberculosis catalase-peroxidase (katG) gene associated with isoniazid resistance. , 1995, The Journal of infectious diseases.